Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05844930 · ClinicalTrials.gov registry record · Phase 4
A Study to Determine the Safety and Effectiveness of a Connective Tissue Allograft (ActiveMatrix) Verses Standard of Care in Adhesive Capsulitis of the Shoulder
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 56
- Enrollment target
NCT05844930 is a Phase 4 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 56 participants.
The verdict
NCT05844930, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 56 participants
- Enrollment target
Study Summary
The purpose of this study is to compare ActiveMatrix® to standard of care corticosteroid injection in the treatment of adhesive capsulitis of the shoulder (frozen shoulder).
Interventions
- DRUG Corticosteroid
- DRUG Lidocaine
- OTHER ActiveMatrix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2023-01-03 |
| Est. Completion | 2025-02-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05844930
The ClinicalTrials.gov registry entry for NCT05844930 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Corticosteroid is the first listed.
NCT05844930 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05844930 about?
NCT05844930 is a clinical study titled "A Study to Determine the Safety and Effectiveness of a Connective Tissue Allograft (ActiveMatrix) Verses Standard of Care in Adhesive Capsulitis of the Shoulder". The purpose of this study is to compare ActiveMatrix® to standard of care corticosteroid injection in the treatment of adhesive capsulitis of the shoulder (frozen shoulder).
What is the current status of trial NCT05844930?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 56 participants. The study started on 2023-01-03. Estimated completion is 2025-02-04.
What interventions are being tested in trial NCT05844930?
The interventions under investigation include: Corticosteroid (DRUG), Lidocaine (DRUG), ActiveMatrix (OTHER).
Who is sponsoring clinical trial NCT05844930?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.